School-based Treatment of Social Anxiety With Developmentally Oriented Cognitive Therapy for Social Anxiety Disorder

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age12-17
SponsorKlaus Ranta

About this trial

The goal of this randomized controlled trial is to find out whether the brief, 10-session Developmentally Oriented Cognitive Therapy for Social Anxiety Disorder (DOCT-SAD) is more effective than standard counseling (SC) to treat Social Anxiety Disorder (SAD) among 12 to 17-year-old adolescents with SAD.

Potential participants for the study are identified from school health and well-being services (SHWS). The DOCT-SAD is delivered by method-trained school psychologists working in the SHWS. SC will be provided by non-method-trained SHWS professionals (i.e. school nurses, social workers or school psychologists) according to their routine counselling practice.

The main research questions of the study are:

1. Is DOCT-SAD more effective than SC for alleviating symptoms of social anxiety? 2. Is DOCT-SAD more effective than SC to produce diagnostic remission from primary SAD and alleviating symptom severity associated with SAD? 3. Is DOCT-SAD more effective than SC for alleviating co-occurring depressive symptoms, interference in daily functioning due to worry or fears, and for increasing general well-being, positive mental health, and for improving the quality of life among adolescents with SAD?

Researchers will compare DOCT-SAD with SC to see if DOCT-SAD is effective in the treatment of SAD in adolescents.

Participants will:

* be treated either with DOCT-SAD or SC for 10 weeks. * be followed up and assessed clinically at six-month and twelve-month follow-up points.

Eligibility criteria

Qualifiers

age 13-17 years

diagnosis of DSM-5 SAD (Social Anxiety Disorder)

SAD is the primary mental health disorder

motivation of the adolescent and parent to attend DOCT-SAD / SC as described in the study protocol

Disqualifiers

intellectual deficit

presence of primary autism spectrum disorder

marked psychotic symptoms or psyhotic disorder

severe eating disorder, depression or primary other anxiety disorder requiring acute treatment which need to be prioritized above treatment of social anxiety

Trial design

Treatments tested in this trial

  • DOCT-SAD
  • SC

Treatment groups

156 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Klaus Ranta

Lead sponsor

Tampere University

Sponsor institution

University of Helsinki

Collaborator

Finnish Institute for Health and Welfare

Collaborator

University of Eastern Finland

Collaborator